Yeshiva University

 Ireland Richard Smith MD and Michael Prystowsky MD phd, of Albert Einstein College of Medicine of Yeshiva University in New York, studied a new class of chemotherapy agents known as histone deacetylase (HDAC) inhibitors, which affect the availability of genes ...

Related articles from Science Daily, Private Healthcare UK, News-Medical.net, Dentistry.co.uk, OneMedPlace, pr-canada.net and more.

 PA Scientists at Albert Einstein College of Medicine of Yeshiva University have combined their revolutionary new drug-delivery system with a powerful antimicrobial agent to treat potentially deadly drug-resistant staph infections in mice. ...

Related articles from RedOrbit, Nanotechnology News, EurekAlert, Meridian Institute, R & D Magazine.

 TX Scientists at Albert Einstein College of Medicine of Yeshiva University have combined their revolutionary new drug-delivery system with a powerful antimicrobial agent to treat potentially deadly drug-resistant staph infections in mice. ...

Related articles from Nanotechnology News, Nanotechwire.com, EurekAlert, Meridian Institute, R & D Magazine.

 DC More] New Technology Shows Promise Against Resistant Staph Infections -- Albert Einstein College of Medicine (5/1/2009) Scientists at Albert Einstein College of Medicine of Yeshiva University, New York, have found a way to treat potentially deadly ...

Related articles from RedOrbit, Nanotechnology News, Nanotechwire.com, EurekAlert, R & D Magazine.

press release) Scientists at Albert Einstein College of Medicine of Yeshiva University have combined their revolutionary new drug-delivery system with a powerful antimicrobial agent to treat potentially deadly drug-resistant staph infections in mice. ...

Related articles from RedOrbit, Nanotechwire.com, EurekAlert, Meridian Institute, R & D Magazine.

 Bulgaria A laboratory study by researchers at Albert Einstein College of Medicine of Yeshiva University suggests that an anti-cancer compound studied for treating blood cancers may also help in treating cancers of the head and neck. The work is reported in the ...

Related articles from Times of India, Press Trust of India, Medical News Today, Spokane Journal of Business, Newspost Online and more.

press release), DC April 29, 2009 — (BRONX, NY) — Scientists at Albert Einstein College of Medicine of Yeshiva University have combined their revolutionary new drug-delivery system with a powerful antimicrobial agent to treat potentially deadly drug-resistant staph ...

Related articles from RedOrbit, Nanotechnology News, Nanotechwire.com, Meridian Institute, R & D Magazine.

 Australia A laboratory study by researchers at Albert Einstein College of Medicine of Yeshiva University suggests that an anti-cancer compound studied for treating blood cancers may also help in treating cancers of the head and neck. The work is reported in the ...

Related articles from Science Daily, Private Healthcare UK, Dentistry.co.uk, OneMedPlace, IrishDentist.ie, pr-canada.net and more.

press release) ScienceDaily (Apr. 29, 2009) — A laboratory study by researchers at Albert Einstein College of Medicine of Yeshiva University suggests that an anti-cancer compound studied for treating blood cancers may also help in treating cancers of the head and ...

Related articles from Private Healthcare UK, News-Medical.net, Dentistry.co.uk, OneMedPlace, IrishDentist.ie, pr-canada.net and more.

 Australia Now, physicians at Albert Einstein College of Medicine of Yeshiva University have shown that a combination of two chemotherapy drugs not only produced clinical benefit for such patients but were also well tolerated. The findings are published online in ...

Related articles from Science Daily, Private Healthcare UK, Dentistry.co.uk, OneMedPlace, IrishDentist.ie, pr-canada.net and more.